Departing Trump AI adviser Sriram Krishnan told the FT that no formal AI licensing regime will be established under the president, saying “there will not be an FDA for AI.” His comments follow the government’s use of export controls to force Anthropic to withdraw Mythos and to hold up OpenAI’s GPT-5.6 release on national security grounds. Krishnan blamed AI labs’ “doomer” messaging for growing public backlash and endorsed Trump’s proposal for AI firms to donate equity to the American people. He favours industry-led oversight over centralised regulation.
Click here for the official article/release
Disclaimer
The Legal Wire takes all necessary precautions to ensure that the materials, information, and documents on its website, including but not limited to articles, newsletters, reports, and blogs (“Materials”), are accurate and complete. Nevertheless, these Materials are intended solely for general informational purposes and do not constitute legal advice. They may not necessarily reflect the current laws or regulations. The Materials should not be interpreted as legal advice on any specific matter. Furthermore, the content and interpretation of the Materials and the laws discussed within are subject to change.
